Company: SYRA
Filing Date: 2025-01-24
Form Type: S-3
Source: 0001493152-25-003630
Chunk: 25

Company: Syra Health Corp
Filing Date: 2025-01-24
Form: S-3
Chunk 25
---
, make distributions or transfer assets; |

| ● | make                                      
 investments or other restricted payments; |

| ● | sell                            
 or otherwise dispose of assets; |

| ● | enter                             
 into sale-leaseback transactions; |

| ● | engage                                           
 in transactions with stockholders or affiliates; |

| ● | issue                                 
 or sell stock of our subsidiaries; or |

| ● | effect                     
 a consolidation or merger; |

| ● | whether                                                                                                                                
 the indenture will require us to maintain any interest coverage, fixed charge, cash flow-based, asset-based or other financial ratios; |

| ● | a                                                                                                                            
 discussion of certain material or special United States federal income tax considerations applicable to the debt securities; |

| ● | information                         
 describing any book-entry features; |

| ● | the                                                            
 applicability of the provisions in the indenture on discharge; |

| ● | whether                                                                                                                      
 the debt securities are to be offered at a price such that they will be deemed to be offered at an “original issue discount” 
 as defined in paragraph (a) of Section 1273 of the Internal Revenue Code of 1986, as amended;                                |

| ● | the                                                                                                                                 
 denominations in which we will issue the series of debt securities, if other than denominations of $1,000 and any integral multiple 
 thereof;                                                                                                                            |

| ● | the                                                                                                                                    
 currency of payment of debt securities if other than U.S. dollars and the manner of determining the equivalent amount in U.S. dollars; 
 and                                                                                                                                    |

| ● | any                                                                                                                                   
 other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities, including any additional events 
 of default or covenants provided with respect to the debt securities, and any terms that may be required by us or advisable under     
 applicable laws or regulations.                                                                                                       |

| -16- |

Conversion or Exchange Rights

We will set forth in the applicable prospectus supplement the terms under which a series of debt securities may be convertible into or exchangeable for our Class A Common Stock, our Preferred Stock or other securities (including securities of a third party). We will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares of our Class A Common Stock, our preferred stock or other securities (including securities of a third party) that the holders of the series of debt securities receive would be subject to adjustment.

Consolid